Advances and applications of induced pluripotent stem cells

被引：0
|
作者：
Pietronave, Stefano [1 ]
Prat, Maria [1 ,2 ]
机构：
[1] Univ Piemonte Orientale, Dept Hlth Sci, Histol Lab, I-28100 Novara, Italy
[2] Ctr Biotecnol Ric Med Applicata BRMA, I-28100 Novara, Italy
来源：
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2012年 / 90卷 / 03期
关键词：
iPS; retrovirus; regenerative medicine; drug discovery; HUMAN FIBROBLASTS; EPIGENETIC MEMORY; OPEN CHROMATIN; SOMATIC-CELLS; BLOOD-CELLS; GENERATION; MOUSE; EFFICIENT; EXPRESSION; INDUCTION;
D O I：
10.1139/Y11-125
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Direct reprogramming of somatic cells into pluripotent cells is an emerging technology for creating patient-specific cells, and potentially opens new scenarios in medical and pharmacological fields. From the discovery of Shinya Yamanaka, who first obtained pluripotent cells from fibroblasts by retrovirus-derived ectopic expression of defined embryonic transcription factors, new methods have been developed to generate safe induced pluripotent stem (iPS) cells without genomic manipulations. This review will focus on the recent advances in iPS technology and their application in pharmacology and medicine.
引用
收藏
页码：317 / 325
页数：9
相关论文
共 50 条
  • [31] Nuclear Reprogramming Strategy Modulates Differentiation Potential of Induced Pluripotent Stem Cells
    Martinez-Fernandez, Almudena
    Nelson, Timothy J.
    Terzic, Andre
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2011, 4 (02) : 131 - 137
  • [32] Potential Applications of Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Gastrointestinal Disorders
    Liu, Shu
    Zhang, Dai
    Chen, Yushuai
    Wang, Bingyuan
    Qiao, Liang
    CURRENT STEM CELL RESEARCH & THERAPY, 2015, 10 (03) : 220 - 227
  • [33] Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell-Based Regeneration
    Yoshida, Yoshinori
    Yamanaka, Shinya
    CIRCULATION, 2010, 122 (01) : 80 - 87
  • [34] Advances in Reprogramming Somatic Cells to Induced Pluripotent Stem Cells
    Minal Patel
    Shuying Yang
    Stem Cell Reviews and Reports, 2010, 6 : 367 - 380
  • [35] Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells
    Ohmine, Seiga
    Dietz, Allan B.
    Deeds, Michael C.
    Hartjes, Katherine A.
    Miller, David R.
    Thatava, Tayaramma
    Sakuma, Toshie
    Kudva, Yogish C.
    Ikeda, Yasuhiro
    STEM CELL RESEARCH & THERAPY, 2011, 2
  • [36] Derivation, characterization and retinal differentiation of induced pluripotent stem cells
    Mekala, Subba Rao
    Vauhini, Vasundhara
    Nagarajan, Usha
    Maddileti, Savitri
    Gaddipati, Subhash
    Mariappan, Indumathi
    JOURNAL OF BIOSCIENCES, 2013, 38 (01) : 123 - 134
  • [37] How induced pluripotent stem cells are redefining personalized medicine
    Ferreira, Leonardo M. R.
    Mostajo-Radji, Mohammed A.
    GENE, 2013, 520 (01) : 1 - 6
  • [38] Induced pluripotent stem cells: Cell therapy in regenerative medicine and modeling of human disease
    Moysidou, E.
    Goulielmaki, M.
    Christodoulou, I
    Zoumpourlis, V
    ARCHIVES OF HELLENIC MEDICINE, 2019, 36 (03): : 300 - 311
  • [39] Research on neurodegenerative diseases using induced pluripotent stem cells
    Imamura, Keiko
    Inoue, Haruhisa
    PSYCHOGERIATRICS, 2012, 12 (02) : 115 - 119
  • [40] Induced pluripotent stem (iPS) cells: A new source for cell-based therapeutics?
    de Lazaro, Irene
    Yilmazer, Acelya
    Kostarelos, Kostas
    JOURNAL OF CONTROLLED RELEASE, 2014, 185 : 37 - 44
12345